NCT Number: NCT07252596
Brief Summary:
The goal of this observational study (case series) is to determine whether Pain Neuroscience Education (PNE) can influence memory function and sensory awareness in adults (18 years and older) experiencing chronic pain lasting more than one year.
The main questions it aims to answer are:
Does a single PNE session improve memory performance, as measured by the Montreal Cognitive Assessment (MoCA)?
Does PNE change sensory awareness, as represented by alterations in body pain drawings using a grid overlay method?
Participants will:
Complete pre-intervention assessments, including:
Numeric Pain Rating Scale (NPRS)
Body chart drawing to map pain area
Montreal Cognitive Assessment (MoCA)
Pain Catastrophization Scale (PCS)
Receive a 10-15 minute standardized PNE session delivered by a licensed clinician trained in pain science
Complete the same assessments immediately after the intervention to identify any changes in memory, sensory awareness, and pain perception
This study aims to explore whether PNE can positively impact cognitive and sensory functions affected by chronic pain, beyond its already-established effects on movement and pain intensity.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Detailed Description:
Chronic pain is a complex, multidimensional condition affecting approximately 25% of the global population. It is increasingly understood through the lens of brain-based changes, particularly the dynamic pain connectome, a network of brain regions involved in sensory, cognitive, and emotional processing. Functional reorganization in chronic pain patients may contribute to clinical symptoms beyond pain, such as memory loss, decreased sensory awareness, and altered motor control.
Pain Neuroscience Education (PNE) is an educational intervention that aims to reconceptualize a patient's understanding of pain to reduce fear-avoidance, pain catastrophization, and disability. Systematic reviews have demonstrated its effectiveness in reducing pain and improving movement. Early fMRI studies suggest that PNE may also deactivate pain-related brain areas and normalize brain function.
This case series seeks to explore the impact of a single PNE session on cognitive (memory) and sensory (body perception) outcomes in individuals with chronic pain. Participants (aged 18 and older) who meet inclusion criteria and consent to the study will undergo pre- and post-intervention assessments. These include:
Numeric Pain Rating Scale (NPRS)
Pain body chart (grid overlay method)
Montreal Cognitive Assessment (MoCA)
Pain Catastrophization Scale (PCS)
Following baseline assessments, participants will receive a 10-15 minute individualized PNE session delivered by licensed clinicians trained in advanced pain science. Immediately post-intervention, assessments will be repeated to evaluate changes.
The study aims to contribute to the understanding of how PNE may influence brain-related symptoms associated with chronic pain, specifically memory function and sensory mapping. Findings could provide early evidence to support broader applications of PNE beyond movement-related outcomes.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A 10-15 minute individualized educational session focusing on the neuroscience of pain. The session aims to reconceptualize the patient's understanding of their chronic pain by explaining the underlying biological, cognitive, and emotional mechanisms involved. Clinicians use a standardized checklist of metaphors and teaching tools tailored to the patient's clinical presentation.
Time frame: At baseline (prior to the pain neuroscience education session) and immediately after completion of the treatment session
Description: Change in MoCA score to assess improvement or decline in cognitive function, particularly memory, associated with chronic pain. The MoCA is scored out of 30; a change of 2 points or more is considered clinically meaningful.
Time frame: At baseline (prior to the pain neuroscience education session) and immediately after completion of the treatment session
Change in the number of grid blocks marked on the body pain chart to quantify alteration in perceived pain area, reflecting somatosensory representation changes.
Time frame: At baseline (prior to the pain neuroscience education session) and immediately after completion of the treatment session
Change in pain intensity reported by the patient on an 11-point scale (0-10). The minimal clinically important difference (MCID) is 1.7 points.
Time frame: At baseline (prior to the pain neuroscience education session) and immediately after completion of the treatment session
Change in PCS scores assessing catastrophic thinking related to pain on a 13-item, 5-point Likert scale. Higher scores indicate greater catastrophizing.
Time frame: Baseline, pre-intervention
Age, gender, ethnicity, pain location, pain duration, family history of pain, presence of memory loss, and spreading of pain since onset.
Time frame: Immediately after intervention
Clinician-reported pain phenotype, diagnosis, metaphors used during PNE, and rating of therapeutic alliance to explore potential influences on intervention effectiveness
Contact information is provided by the study sponsor or research team.
Evidence In Motion
Other
Pain Neuroscience Education's Effect on Memory and Pain Drawings: An Exploratory Study
Acronym: PNE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07740681
Chronic Pain, Neurologic Manifestations
View Trial DetailsNCT07696923
Adhesive Capsulitis, Bursitis
Taipei, Taiwan
View Trial DetailsNCT07641504
Back Pain, Chronic Pain
Birmingham, Alabama, United States
View Trial DetailsNCT07717762
Acute Pain, Chronic Pain
Bern, Canton of Bern, Switzerland
View Trial Details